Th17 has pro-inflammatory activity, and many studies have shown that Th17 and its related cytokines increased significantly in COPD patients and COPD animal models, and enhanced the airway inflammatory response by secreting pro-inflammatory factors such as IL-6 and IL-17, which further led to tissue damage [27–29]. This evidence concerns the gene IL6 and chronic obstructive pulmonary disease.